Published in Br J Rheumatol on September 01, 1998
Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci U S A (1999) 5.96
Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies. PLoS Med (2011) 2.64
Development of macromolecular prodrug for rheumatoid arthritis. Adv Drug Deliv Rev (2012) 1.07
COX-1 and COX-2 products in the gut: therapeutic impact of COX-2 inhibitors. Gut (2000) 0.94
Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors. Drug Healthc Patient Saf (2009) 0.94
Aspirin and other anti-inflammatory drugs. Thorax (2000) 0.93
Pharmacological basis for the therapy of pain and inflammation with nonsteroidal anti-inflammatory drugs. Arthritis Res (2000) 0.91
The incidence of adverse events and risk factors for upper gastrointestinal disorders associated with meloxicam use amongst 19,087 patients in general practice in England: cohort study. Br J Clin Pharmacol (2000) 0.90
Cost-effectiveness of strategies for primary prevention of nonsteroidal anti-inflammatory drug-induced peptic ulcer disease. J Gen Intern Med (2000) 0.89
Suppressive effects of N-acetyl-D-glucosamine on rheumatoid arthritis mouse models. Inflammation (2012) 0.89
Cyclooxygenase inhibition: between the devil and the deep blue sea. Gut (2002) 0.85
Transition of treatment for patients with extra-abdominal desmoid tumors: nagoya university modality. Cancers (Basel) (2012) 0.84
Review of the cardiovascular safety of COXIBs compared to NSAIDS. Cardiovasc J Afr (2008) 0.83
NSAID-Induced Enteropathy in Rheumatoid Arthritis Patients with Chronic Occult Gastrointestinal Bleeding: A Prospective Capsule Endoscopy Study. Gastroenterol Res Pract (2013) 0.80
Outcomes studies of drug induced ulcer complications: do we need them and how should they be done? BMJ (2000) 0.79
Small bowel injury induced by selective cyclooxygenase-2 inhibitors: a prospective, double-blind, randomized clinical trial comparing celecoxib and meloxicam. J Gastroenterol (2011) 0.77
Steady-state pharmacokinetics of lithium in healthy volunteers receiving concomitant meloxicam. Br J Clin Pharmacol (2000) 0.77
Ameliorative effect of ocimum sanctum on meloxicam induced toxicity in wistar rats. Toxicol Int (2011) 0.76
Use of a once-daily NSAID in treatment of cyclic vomiting syndrome. J Gen Intern Med (2013) 0.76
Assessment of the safety of selective cyclo-oxygenase-2 inhibitors: where are we in 2003? Inflammopharmacology (2003) 0.76
An appraisal of innovative meloxicam mucoadhesive films for periodontal postsurgical pain control: A double-blinded, randomized clinical trial of effectiveness. Contemp Clin Dent (2015) 0.75
Network Meta-Analysis Comparing Relatively Selective COX-2 Inhibitors Versus Coxibs for the Prevention of NSAID-Induced Gastrointestinal Injury. Medicine (Baltimore) (2015) 0.75
Re: Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients (C. Hawkey et al., Br J Rheumatol 1998;37:937-45) Rheumatology (Oxford) (1999) 0.75
[Pharmacology of cyclooxygenase 2 inhibition]. Wien Med Wochenschr (2003) 0.75
[Cyclooxygenase 2 selective antirheumatic analgesics]. Wien Med Wochenschr (2003) 0.75
Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group. N Engl J Med (1996) 11.76
Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med (1995) 10.99
Direct three-dimensional morphometric analysis of human cancellous bone: microstructural data from spine, femur, iliac crest, and calcaneus. J Bone Miner Res (1999) 6.39
Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N Engl J Med (1989) 3.68
Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis. Lancet (1990) 3.55
Incidence of vertebral fracture in europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res (2002) 3.16
Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int (1999) 2.70
Growth hormone treatment for sustained pain reduction and improvement in quality of life in severe fibromyalgia. Pain (2012) 2.69
Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French Pharmacovigilance Centres. BMJ (2000) 2.49
[Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France]. Therapie (1985) 2.41
Camptodactyly in a painting by Dirk Bouts (c. 1410-1475). J R Soc Med (2004) 2.28
Interspecies differences in bone composition, density, and quality: potential implications for in vivo bone research. Endocrinology (1998) 2.24
Morphometric analysis of human bone biopsies: a quantitative structural comparison of histological sections and micro-computed tomography. Bone (1998) 2.18
The relationship between osteoporosis and osteoarthritis. Clin Rheum Dis (1985) 2.14
Vertebral and peripheral bone mineral content and fracture incidence in postmenopausal patients with rheumatoid arthritis: effect of low dose corticosteroids. Ann Rheum Dis (1986) 2.13
Ten year mortality and causes of death in patients with rheumatoid arthritis. Br Med J (Clin Res Ed) (1985) 2.10
Antipsychotic prescribing trends: a review of pharmaco-epidemiological studies. Acta Psychiatr Scand (2009) 2.07
Arthritis in Flemish paintings (1400-1700). Br Med J (1977) 2.03
Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: a case/non-case study in the French pharmacovigilance system database. Br J Clin Pharmacol (1997) 2.02
Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability. Eur J Clin Pharmacol (2000) 2.01
Effect of gold treatment on the progression of erosions in RA patients. Scand J Rheumatol (1977) 2.01
Cardiovascular mortality in women with rheumatoid arthritis. J Rheumatol (1995) 1.96
Pressure pain threshold in pain-free subjects, in patients with chronic regional pain syndromes, and in patients with fibromyalgia syndrome. Arthritis Rheum (1993) 1.95
High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis. Arthritis Rheum (2008) 1.90
Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis. Arthritis Rheum (2009) 1.88
Bone mass in osteoarthrosis, measured in vivo by photon absorption. J Bone Joint Surg Am (1974) 1.85
Benzodiazepines and hip fractures in elderly people: case-control study. BMJ (2001) 1.85
How Renoir coped with rheumatoid arthritis. BMJ (1998) 1.84
Elevated cancer incidence in patients with dermatomyositis: a population based study. J Rheumatol (1995) 1.84
Risk factors for hip fracture in European women: the MEDOS Study. Mediterranean Osteoporosis Study. J Bone Miner Res (1995) 1.79
Under-reporting of adverse drug reactions in general practice. Br J Clin Pharmacol (1997) 1.78
Under-reporting of adverse drug reactions. Estimate based on a spontaneous reporting scheme and a sentinel system. Eur J Clin Pharmacol (1998) 1.78
[Iatrogenic medication: estimation of its prevalence in French public hospitals. Regional Centers of Pharmacovigilance]. Therapie (1999) 1.72
Death attributed to antirheumatic medication in a nationwide series of 1666 patients with rheumatoid arthritis who have died. J Rheumatol (1995) 1.66
Yersinia specific immune complexes in the synovial fluid of patients with yersinia triggered reactive arthritis. Ann Rheum Dis (1987) 1.63
Rheumatoid lymphedema. J Rheumatol (1987) 1.62
Assessment of the strength of proximal femur in vitro: relationship to femoral bone mineral density and femoral geometry. Bone (1997) 1.62
Risk factors for hip fracture in men from southern Europe: the MEDOS study. Mediterranean Osteoporosis Study. Osteoporos Int (1999) 1.59
Increased prevalence of ocular glaucomatous abnormalities in systemic sclerosis. Ann Rheum Dis (2004) 1.59
Does hip strength analysis explain the lower incidence of hip fracture in the People's Republic of China? Bone (2004) 1.57
Incidence of limb fracture across Europe: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int (2002) 1.56
Nosocomial infections by chlorhexidine solution contaminated with Pseudomonas pickettii (Biovar VA-I). J Infect (1983) 1.55
Spontaneous reporting: how many cases are required to trigger a warning? Br J Clin Pharmacol (1991) 1.55
The European Spine Phantom--a tool for standardization and quality control in spinal bone mineral measurements by DXA and QCT. Eur J Radiol (1995) 1.51
Methotrexate osteopathy, does it exist? J Rheumatol (1996) 1.50
Accuracy of self-report and toxicological assays to detect substance misuse disorders in parasuicide patients. Acta Psychiatr Scand (2003) 1.48
Three cases of typical aplastic anaemia associated with a Philadelphia chromosome. Br J Haematol (2001) 1.48
Increased nitric oxide in exhaled air in patients with systemic sclerosis. Clin Exp Rheumatol (1998) 1.48
Osteoporosis and osteoarthritis (osteoarthrosis). Anthropometric distinctions. JAMA (1983) 1.47
The variable incidence of hip fracture in southern Europe: the MEDOS Study. Osteoporos Int (1994) 1.46
Determinants of incident vertebral fracture in men and women: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int (2003) 1.45
Fibromyalgia and disability. Report of the Moss International Working Group on medico-legal aspects of chronic widespread musculoskeletal pain complaints and fibromyalgia. Scand J Rheumatol (1995) 1.44
The accuracy of peripheral skeletal assessment at the radius in estimating femoral bone density as measured by dual-energy X-ray absorptiometry: a comparative study of single-photon absorptiometry and computed tomography. J Intern Med (1997) 1.44
STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis. Arthritis Rheum (2009) 1.43
Rheumatic manifestations in patients with thromboangiitis obliterans (Buerger's disease). J Rheumatol (1999) 1.40
Eosinophilia-myalgia linked with L-tryptophan. Lancet (1990) 1.39
Deficiency of the growth hormone-insulin-like growth factor-I axis potentially involved in age-related alterations in body composition. Gerontology (1996) 1.39
Effectiveness and safety profile of leflunomide in rheumatoid arthritis: actual practice compared with clinical trials. Clin Exp Rheumatol (2005) 1.39
Nifedipine and thallium-201 myocardial perfusion in progressive systemic sclerosis. N Engl J Med (1986) 1.38
Total lymphoid irradiation in rheumatoid arthritis. A ten-year followup. Arthritis Rheum (1997) 1.38
Mortality from cancer in patients with rheumatoid arthritis. Scand J Rheumatol (1995) 1.37
High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series. J Clin Oncol (1998) 1.37
A systematic survey of HLA-A,B,C and D antigens and drug toxicity in rheumatoid arthritis. J Rheumatol (1984) 1.36
Effect of gold on progression of erosions in rheumatoid arthritis. Better results with early treatment. Scand J Rheumatol (1977) 1.35
Multifocal stenosing ulcerations of the small intestine revealing vasculitis associated with C2 deficiency. Gastroenterology (1996) 1.32
Amitriptyline in the treatment of fibromyalgia: a systematic review of its efficacy. Rheumatology (Oxford) (2008) 1.31
Radiological hand involvement in systemic sclerosis. Ann Rheum Dis (2006) 1.28
Three-dimensional analysis of shear wave propagation observed by in vivo magnetic resonance elastography of the brain. Acta Biomater (2006) 1.28
Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA ("Groupe d'Etude des Lymphomes de l'Adulte") study. Am J Surg Pathol (1996) 1.27
Retinal toxicity in long term hydroxychloroquine treatment. Ann Rheum Dis (1996) 1.27
Increased biosynthesis of complement components by cultured monocytes, synovial fluid macrophages and skynovial membrane cells from patients with rheumatoid arthritis. Immunology (1980) 1.26
Shift in the incidence of rheumatoid arthritis toward elderly patients in Finland during 1975-1990. Clin Exp Rheumatol (1997) 1.24
Hip geometry, bone mineral distribution, and bone strength in European men and women: the EPOS study. Bone (2000) 1.23
Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population. Ann Rheum Dis (2010) 1.22
Evaluation of cardiac abnormalities by Doppler echocardiography in a large nationwide multicentric cohort of patients with systemic sclerosis. Ann Rheum Dis (2007) 1.21
Quantitative radiology: radiogrammetry of cortical bone. Br J Radiol (1976) 1.20
Prevalent vertebral deformity predicts incident hip though not distal forearm fracture: results from the European Prospective Osteoporosis Study. Osteoporos Int (2001) 1.20
Epidemiology of aplastic anemia in France: a prospective multicentric study. The French Cooperative Group for Epidemiological Study of Aplastic Anemia. Blood (1990) 1.20
NLRP1 influences the systemic sclerosis phenotype: a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesis. Ann Rheum Dis (2010) 1.19
Physical and histomorphological characteristics of iliac crest bone differ according to the grade of osteoarthritis at the hand. Bone (1989) 1.19
Benzodiazepine use in an elderly community-dwelling population. Characteristics of users and factors associated with subsequent use. Eur J Clin Pharmacol (2001) 1.19
Elevated incidence of hematologic malignancies in patients with Sjögren's syndrome compared with patients with rheumatoid arthritis (Finland). Cancer Causes Control (1997) 1.18
Power and weakness of spontaneous reporting: a probabilistic approach. J Clin Epidemiol (1992) 1.17
Systemic sclerosis-associated Sjögren's syndrome and relationship to the limited cutaneous subtype: results of a prospective study of sicca syndrome in 133 consecutive patients. Arthritis Rheum (2006) 1.14
Chronic recurrent multifocal osteomyelitis: five-year outcomes in 14 pediatric cases. Joint Bone Spine (2001) 1.14
Shortening of life span and causes of excess mortality in a population-based series of subjects with rheumatoid arthritis. Clin Exp Rheumatol (1995) 1.13
Causes of death in autopsied RA patients. Scand J Rheumatol (1976) 1.13
Ageing of bone: its relation to osteoporosis and osteoarthrosis in post-menopausal women. Front Horm Res (1975) 1.13
Fluoride kinetics of the axial skeleton measured in vivo with fluorine-18-fluoride PET. J Nucl Med (1997) 1.12